GFC Life Science (Co-CEOs Kang Hee-chul and Pyo Hyeong-bae), a bio-dermatology company, announced on the 22nd that it has signed a strategic partnership with Taiwanese skincare brand Relove and granted it exclusive rights to use its exosome raw materials, Lakei-Exo (EH) and Leuco-Exo (EPH), in Taiwan.
Through this agreement, Relove has secured the right to exclusively develop and commercialize products using the raw materials in the Taiwanese market. GFC Life Science plans to use this as an opportunity to expand technology exports to the Asian region and strengthen its position in the global bio-raw material market.
Lakei-Exo (EH) and Leuco-Exo (EPH) supplied by GFC Life Science are high-purity cell-derived exosome-based raw materials that are used in various dermatological products based on their efficacy such as skin regeneration, anti-aging, and soothing.
Relove is a skincare brand with annual sales of approximately 500 million Taiwan dollars (approximately 23 billion won). It distributes its products through department stores, pharmacies, drugstores, and online channels throughout Taiwan, and is also pursuing overseas expansion into Hong Kong, China, Japan, Malaysia, and North America.
A representative of Relove stated, “We pursued this collaboration in order to strengthen our exosome skincare line that focuses on functionality,” and “We expect that GFC Life Science’s raw materials will fit our brand strategy and increase consumer satisfaction.”
“This partnership will be an opportunity to demonstrate the company’s technological prowess and reliability in the global market,” said Kang Hee-chul, CEO of GFC Life Science. “We are pursuing expansion into the Asian market starting with Taiwan, and are also considering advancing into North America and Europe.”
- See more related articles
You must be logged in to post a comment.